Industry News
Positive top-line Phase III results from clinical study with GRASPA(R) in Acute Lymphoblastic Leukemia
Oct 02, 2014
ERYTECH, the French biopharmaceutical company that develops innovative 'tumor starvation' treatments for acute leukemia and other oncology indications with unmet medical needs, reports positive... Read More
Potential treatments for breast, ovarian and other cancers with new discovery approach
Oct 02, 2014
Researchers at the University of Michigan have described a new approach to discovering potential cancer treatments that requires a fraction of the time needed for more traditional methods. Read More
Nine-valent HPV vaccine may prevent nearly 90 percent of cervical cancers
Oct 02, 2014
Because nine human papillomavirus (HPV) subtypes were found to cause the majority of cervical precancers, a nine-valent HPV vaccine currently being investigated may be able to prevent more cervical... Read More
Novel rose bengal formulation obliterates lesions in patients with deadliest of melanomas
Oct 02, 2014
A formulation of the dye, rose bengal, which has been around for more than a century, has recently been shown to have promise in patients with cutaneous melanoma, one of the deadliest forms of the... Read More
Positive top-line Phase III results from clinical study with GRASPA(R) in Acute Lymphoblastic Leukemia
Oct 02, 2014
ERYTECH, the French biopharmaceutical company that develops innovative 'tumor starvation' treatments for acute leukemia and other oncology indications with unmet medical needs, reports positive... Read More
Crizotinib Effective in Phase 1 Trial Against ROS1 Lung Cancer
Oct 02, 2014
The New England Journal of Medicine reports positive results of a phase 1 clinical trial of the drug crizotinib against the subset of lung cancer marked by rearrangement of the gene ROS1. Read More
Nine-valent HPV vaccine may prevent nearly 90 percent of cervical cancers
Oct 02, 2014
Because nine human papillomavirus (HPV) subtypes were found to cause the majority of cervical precancers, a nine-valent HPV vaccine currently being investigated may be able to prevent more cervical... Read More
Cancer therapy: Driving cancer cells to suicide
Oct 02, 2014
Researchers of Ludwig-Maximilians-Universitaet (LMU) in Munich report that a new class of chemical compounds makes cancer cells more sensitive to chemotherapeutic drugs. Read More
Mammographic density offers potential to improve prediction of breast cancer risk and development of personalized screening
Oct 02, 2014
The accurate measurement of mammographic density offers the potential to improve breast cancer risk prediction and to tailor screening protocols according to risk, according to a study published in... Read More
Potential treatments for breast, ovarian and other cancers with new discovery approach
Oct 02, 2014
Researchers at the University of Michigan have described a new approach to discovering potential cancer treatments that requires a fraction of the time needed for more traditional methods. Read More
Previous Page Next Page